NeuroEquilibrium In Talks To Raise $2 M In Series A

Dr. Anita Bhandari
M.S. in ENT from SMS Medical College | Ph.D. in Vestibular Science from Maastricht University

TL:DR;

Funding Plans: NeuroEquilibrium plans to raise $2 million in Series A funding within the next four months, after receiving $250,000 in seed funding from Unicorn India Ventures. Funds will expand clinics and operations while offering partial ownership to new investors.
Clinic Network: Founded in 2014, aims to establish 125 clinics by July 2018. Currently operates 12 clinics in cities like Delhi, Mumbai, Patna, and even Cyprus in Europe.
Global Expansion: Plans to expand to countries including Bangladesh, Nepal, parts of Africa, and Southeast Asia with the new funding.
Technology: Uses cloud-based technology to diagnose and treat vertigo, improving doctors’ ability to evaluate patients effectively.
Future Fundraising: May raise more money in the future and is in discussions with venture capital firms, though specific names are not disclosed.

Receives $2,50,000 in seed funding from Unicorn India Ventures

NeuroEquilibrium Diagnostics Systems is in talks to raise about $2 million in Series A funding, expected to be concluded in the next four months, in exchange for a minority stake. Separately, the healthcare start-up raised $2,50,000 in seed funding from Unicorn India Ventures last week.

The company, bootstrapped in 2014, will use the funds to set up 125 clinics by July 2018 in India and foreign locales. At present, the company has 12 clinics across Delhi, Mumbai, Patna, Hubli, West Bengal and Cyprus in Europe.

“This funding will be sufficient for the present expansion plans. We are also planning to foray into Africa and certain South-East Asian markets, while we are in advanced discussions to move into Bangladesh and Nepal,” said Rajneesh Bhandari, founder and Managing Director, NeuroEquilibrium.

The company, which usesCloud technologies to evaluate and diagnose vertigo, will look at raising further funds, if needed, he said, adding that the company has initiated talks with a clutch of top venture capitals.

Bhandari, however, declined to name the VCs as the talks have not reached a conclusive stage.

The seed funding raised from Unicorn India, a SEBI-approved fund, is a convertible round at a discount to the series A round.

Explore More About NeuroEquilibrium:

Source: Link

TL:DR;

Funding Plans: NeuroEquilibrium plans to raise $2 million in Series A funding within the next four months, after receiving $250,000 in seed funding from Unicorn India Ventures. Funds will expand clinics and operations while offering partial ownership to new investors.
Clinic Network: Founded in 2014, aims to establish 125 clinics by July 2018. Currently operates 12 clinics in cities like Delhi, Mumbai, Patna, and even Cyprus in Europe.
Global Expansion: Plans to expand to countries including Bangladesh, Nepal, parts of Africa, and Southeast Asia with the new funding.
Technology: Uses cloud-based technology to diagnose and treat vertigo, improving doctors’ ability to evaluate patients effectively.
Future Fundraising: May raise more money in the future and is in discussions with venture capital firms, though specific names are not disclosed.

Disclaimer: The information provided on this website is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.

✅ Content reviewed by

Last Modified: August 26, 2025